The company's balance sheet is not considered strong due to ...

The company's balance sheet is not considered strong due to its high debt and liabilities, coupled with a decrease in revenue and a loss before interest and tax. The company is considered risky due to these factors.

Hybio Pharmaceutical (SZSE:300199) Is Making Moderate Use Of Debt

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

1216 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3722Followers

0Following

8632Visitors